SCHEMBL2580673

SCHEMBL2580673

CCOC(=O)CCCCC(S)CCS

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
KMT2A Q03164 2/20 0.44
TDP1 Q9NUW8 3/20 0.41
CYP3A4 P08684 2/20 0.41
TSHR P16473 2/20 0.41
ALDH1A1 P00352 2/20 0.41
ALOX15 P16050 2/20 0.41
POLB P06746 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ATM Q13315 1/20 0.40
NR1I2 O75469 1/20 0.39
PGR P06401 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
PTGS2 P35354 1/20 0.39
PDE4D Q08499 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
DGKA P23743 1/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2580934 0.98 CYP1A2 (0.46) CYP1A2KMT2ATDP1CYP3A4TSHR
SCHEMBL16480294 0.86 DGKA (0.45) CYP1A2KMT2ATDP1CYP3A4TSHR
SCHEMBL8095315 0.85 DGKA (0.51) KMT2ATDP1CYP3A4TSHRALDH1A1
SCHEMBL9315300 0.83 DGKA (0.57) KMT2ATSHRALDH1A1DGKAMAPT
SCHEMBL16312502 0.83 DGKA (0.43) TDP1CYP3A4TSHRALDH1A1ATM
SCHEMBL7778506 0.82 TSHR (0.50) KMT2ATSHRALDH1A1HSD17B10L3MBTL1
SCHEMBL16374096 0.82 DGKA (0.43) TDP1CYP3A4TSHRALDH1A1ATM
SCHEMBL5855176 0.81 CYP1A2 (0.46) CYP1A2KMT2ATDP1CYP3A4TSHR
SCHEMBL8102988 0.81 DNM1 (0.58) CYP1A2TDP1CYP3A4TSHRALDH1A1
SCHEMBL7789654 0.81 CYP1A2 (0.42) CYP1A2KMT2ATDP1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118480026-A Preparation method of lipoic acid impurity A 苏州富士莱医药股份有限公司 2024-08-13 CN claimed
US-20060122100-A1 Melanin extinguisher OGA RESEARCH, INCORPORATED (JP) 2006-06-08 US claimed
CN-1681490-A Melanin extinguisher OGA RES INC (JP) 2005-10-12 CN claimed
EP-1547590-A1 MELANIN EXTINGUISHER Oga Research, Incorporated (JP) 2005-06-29 EP claimed
CN-118480026-A Preparation method of lipoic acid impurity A 苏州富士莱医药股份有限公司 2024-08-13 CN disclosed
CN-118480026-A Preparation method of lipoic acid impurity A 苏州富士莱医药股份有限公司 2024-08-13 CN disclosed
US-8048911-B2 Melanin eliminator preparation OGA Research, Inc. (JP) 2011-11-01 US disclosed
US-20090093541-A1 MELANIN ELIMINATOR PREPARATION OGA RESEARCH, INC (JP) 2009-04-09 US disclosed
CN-100367949-C Melanin extinguisher OGA RES INC (JP) 2008-02-13 CN disclosed
US-20060122100-A1 Melanin extinguisher OGA RESEARCH, INCORPORATED (JP) 2006-06-08 US disclosed
CN-1681490-A Melanin extinguisher OGA RES INC (JP) 2005-10-12 CN disclosed
EP-1547590-A1 MELANIN EXTINGUISHER Oga Research, Incorporated (JP) 2005-06-29 EP disclosed
US-3979369-A DIENE POLYMER MONSANTO COMPANY (US) 1976-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122100-A1 Melanin extinguisher TYR, MC1R, MITF CYP1A2 3011/4885KMT2A 1597/4885TDP1 4226/4885
US-20090093541-A1 MELANIN ELIMINATOR PREPARATION TYR, MC1R, MCHR1 CYP1A2 1237/4885KMT2A 1749/4885TDP1 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.